Myotonic dystrophy type 1 is a rare, dominantly inherited, progressive, disabling, neuromuscular disease that leads to decreased life expectancy and has no approved therapies. The disease is caused by ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted breakthrough therapy designation to a proprietary oligonucleotide conjugate for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results